PQ-313-002 “A first in human, double-blind, randomized, intra-subject placebo-controlled, multiple dose study of QR-313 evaluating safety, proof of mechanism, preliminary efficacy and systemic exposure in subjects with Recessive Dystrophic

Project: Research project

Description

PQ-313-002 “A first in human, double-blind, randomized, intra-subject placebo-controlled, multiple dose study of QR-313 evaluating safety, proof of mechanism, preliminary efficacy and systemic exposure in subjects with Recessive Dystrophic
StatusActive
Effective start/end date7/23/1812/30/22

Funding

  • ProQR Therapeutics

Fingerprint

Placebos
Safety